| scholarly article | Q13442814 |
| P2093 | author name string | Alan F Sved | |
| Eric C Donny | |||
| Tracy T Smith | |||
| Laura E Rupprecht | |||
| Rachel L Denlinger-Apte | |||
| Jillian J Weeks | |||
| Rachel S Panas | |||
| P2860 | cites work | Age differences in the spontaneous acquisition of nicotine self-administration in male Wistar and Long-Evans rats | Q46880882 |
| Nicotine replacement: effects of postcessation weight gain | Q47174203 | ||
| Tobacco particulate matter self-administration in rats: differential effects of tobacco type | Q47777284 | ||
| Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days | Q48418098 | ||
| Adolescent nicotine or cigarette smoke exposure changes subsequent response to nicotine conditioned place preference and self-administration | Q48680201 | ||
| Threshold dose for behavioral discrimination of cigarette nicotine content in menthol vs. non-menthol smokers | Q50455473 | ||
| Nicotine-like behavioral effects of the minor tobacco alkaloids nornicotine, anabasine, and anatabine in male rodents | Q50691330 | ||
| Adolescent obesity as a risk factor for high-level nicotine addiction in young women | Q50998931 | ||
| Acquisition of nicotine self-administration in adolescent rats given prolonged access to the drug. | Q51798710 | ||
| Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats. | Q51996777 | ||
| Nornicotine is self-administered intravenously by rats. | Q52172593 | ||
| Association of Cigarettes Smoked Daily with Obesity in a General Adult Population* | Q58745224 | ||
| Age of smoking initiation: implications for quitting | Q77629415 | ||
| New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure | Q80163465 | ||
| Novel nicotine delivery systems and public health: the rise of the "e-cigarette" | Q82416279 | ||
| A lost opportunity for public health--the FDA advisory committee report on menthol | Q84035309 | ||
| Inhibition of monoamine oxidase B in the brains of smokers | Q24322939 | ||
| Obese Smokers as a Potential Subpopulation of Risk in Tobacco Reduction Policy | Q26785452 | ||
| How Menthol Alters Tobacco-Smoking Behavior: A Biological Perspective | Q26785456 | ||
| Smoking Use and Cessation Among People with Serious Mental Illness | Q26785461 | ||
| Predictors of the nicotine reinforcement threshold, compensation, and elasticity of demand in a rodent model of nicotine reduction policy | Q27312260 | ||
| Electronic cigarette use among working adults - United States, 2014 | Q27908629 | ||
| Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats | Q28273463 | ||
| The adolescent brain and age-related behavioral manifestations | Q29618654 | ||
| Predicted Impact of Nicotine Reduction on Smokers with Affective Disorders. | Q30380558 | ||
| Reinforcement enhancing effects of nicotine via smoking | Q30428258 | ||
| Sex and ovarian hormones influence vulnerability and motivation for nicotine during adolescence in rats | Q30434367 | ||
| Comparison of the reinforcing properties of nicotine and cigarette smoke extract in rats | Q33764231 | ||
| Brain monoamine oxidase A inhibition in cigarette smokers | Q34063791 | ||
| Conditioned place preference and self-administration induced by nicotine in adolescent and adult rats | Q34360535 | ||
| Smoking and mental illness in the U.S. population | Q34362758 | ||
| Randomized Trial of Reduced-Nicotine Standards for Cigarettes. | Q34496332 | ||
| Cue dependency of nicotine self-administration and smoking. | Q34498025 | ||
| Enhancing effect of menthol on nicotine self-administration in rats | Q34535780 | ||
| Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation | Q34621879 | ||
| Menthol facilitates the intravenous self-administration of nicotine in rats | Q34708488 | ||
| Compensatory smoking from gradual and immediate reduction in cigarette nicotine content | Q35071508 | ||
| Animal models to assess the abuse liability of tobacco products: effects of smokeless tobacco extracts on intracranial self-stimulation. | Q35110020 | ||
| Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats | Q35188133 | ||
| Cigarette smoking, nicotine, and body weight | Q35369070 | ||
| Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers | Q35785036 | ||
| Behavioral mechanisms underlying nicotine reinforcement | Q35954791 | ||
| Nicotine Dependence, Nicotine Metabolism, and the Extent of Compensation in Response to Reduced Nicotine Content Cigarettes. | Q35974959 | ||
| Low-dose nicotine self-administration is reduced in adult male rats naïve to high doses of nicotine: implications for nicotine product standards | Q35976930 | ||
| Delivery of nicotine in an extract of a smokeless tobacco product reduces its reinforcement-attenuating and discriminative stimulus effects in rats | Q35997407 | ||
| Sex differences in conditioned nicotine reward are age-specific | Q36004637 | ||
| Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. | Q36047601 | ||
| Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up. | Q36047868 | ||
| Effects of MAO inhibition and a combination of minor alkaloids, β-carbolines, and acetaldehyde on nicotine self-administration in adult male rats | Q36090344 | ||
| Nicotine reduction revisited: science and future directions | Q36201699 | ||
| Industry research on the use and effects of levulinic acid: a case study in cigarette additives | Q36271279 | ||
| Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls | Q36471948 | ||
| Monoamine oxidase and tobacco dependence. | Q36543315 | ||
| Impact of tobacco regulation on animal research: new perspectives and opportunities | Q36727831 | ||
| Threshold dose for discrimination of nicotine via cigarette smoking | Q36917735 | ||
| Reduced nicotine content cigarettes and nicotine patch | Q36927046 | ||
| Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes | Q37169244 | ||
| Gradual and immediate nicotine reduction result in similar low-dose nicotine self-administration | Q37215565 | ||
| Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine. | Q37304946 | ||
| Sex differences in nicotine self-administration in rats during progressive unit dose reduction: implications for nicotine regulation policy | Q37519158 | ||
| Nicotine is more addictive, not more cognitively therapeutic in a neurodevelopmental model of schizophrenia produced by neonatal ventral hippocampal lesions | Q37565145 | ||
| Adolescence is a period of development characterized by short- and long-term vulnerability to the rewarding effects of nicotine and reduced sensitivity to the anorectic effects of this drug | Q37662116 | ||
| Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence. | Q37877612 | ||
| Self-administered nicotine differentially impacts body weight gain in obesity-prone and obesity-resistant rats | Q38965752 | ||
| Self-administration of nicotine and cigarette smoke extract in adolescent and adult rats | Q39653755 | ||
| Self-Administered Nicotine Suppresses Body Weight Gain Independent of Food Intake in Male Rats | Q39754694 | ||
| Adolescent Rats Self-Administer Less Nicotine Than Adults at Low Doses | Q40110624 | ||
| Current cigarette smoking among adults - United States, 2005-2014. | Q40328471 | ||
| Effects of Cigarette Smoking on Psychopathology Scores in Patients With Schizophrenia: An Experimental Study | Q40617490 | ||
| The impact of flavoring on the rewarding and reinforcing value of e-cigarettes with nicotine among young adult smokers | Q40647261 | ||
| Tobacco use among middle and high school students - United States, 2011-2014. | Q41064947 | ||
| The role of nicotine in smoking: a dual-reinforcement model. | Q41559912 | ||
| Smoking Topography Characteristics of Very Low Nicotine Content Cigarettes, With and Without Nicotine Replacement, in Smokers With Schizophrenia and Controls | Q41971019 | ||
| Effects of Monoamine Oxidase Inhibition on the Reinforcing Properties of Low-Dose Nicotine | Q42418777 | ||
| Conditioned reinforcement in rats established with self-administered nicotine and enhanced by noncontingent nicotine | Q42930770 | ||
| Intravenous self-administration of ethanol and acetaldehyde by rats | Q43655348 | ||
| Adolescent-onset nicotine self-administration modeled in female rats | Q44452279 | ||
| Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement | Q44458252 | ||
| Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats. | Q44477233 | ||
| Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats | Q45117312 | ||
| Reduced nicotine reward in obesity: cross-comparison in human and mouse | Q45272359 | ||
| The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats. | Q46051348 | ||
| Establishing a nicotine threshold for addiction. The implications for tobacco regulation | Q46058830 | ||
| Reduced nicotine content cigarettes, e-cigarettes and the cigarette end game | Q46067537 | ||
| Nicotine-, tobacco particulate matter- and methamphetamine-produced locomotor sensitisation in rats | Q46143485 | ||
| Tranylcypromine enhancement of nicotine self-administration. | Q46182407 | ||
| Reducing nicotine exposure results in weight gain in smokers randomised to very low nicotine content cigarettes | Q46258132 | ||
| Reinforcing and neural activating effects of norharmane, a non-nicotine tobacco constituent, alone and in combination with nicotine | Q46543968 | ||
| P577 | publication date | 2017-04-04 | |
| P1433 | published in | Nicotine and Tobacco Research | Q15762854 |
| P1476 | title | Animal research on nicotine reduction: Current evidence and research gaps |
| Q50061646 | Reducing the Prevalence of Smoking: Policy Measures and Focusing on Specific Populations |
| Q92194047 | Research on Behavioral Discrimination of Nicotine May Inform FDA Policy on Setting a Maximum Nicotine Content in Cigarettes |
| Q57171561 | Status and Future Directions of Preclinical Behavioral Pharmacology in Tobacco Regulatory Science |
Search more.